↓ Skip to main content

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in…

Overview of attention for article published in Frontiers in Pharmacology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
Published in
Frontiers in Pharmacology, May 2023
DOI 10.3389/fphar.2023.1093396
Pubmed ID
Authors

Lukas Fiedler, Lukas J. Motloch, Anna-Maria Dieplinger, Peter Jirak, Paruir Davtyan, Diana Gareeva, Elena Badykova, Marat Badykov, Irina Lakman, Aleksandr Agapitov, Liana Sadikova, Valentin Pavlov, Fabian Föttinger, Moritz Mirna, Kristen Kopp, Uta C. Hoppe, Rudin Pistulli, Benzhi Cai, Baofeng Yang, Naufal Zagidullin

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 33%
Researcher 1 17%
Unknown 3 50%
Readers by discipline Count As %
Nursing and Health Professions 1 17%
Computer Science 1 17%
Medicine and Dentistry 1 17%
Unknown 3 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2023.
All research outputs
#19,402,406
of 23,870,007 outputs
Outputs from Frontiers in Pharmacology
#8,960
of 17,727 outputs
Outputs of similar age
#173,691
of 241,767 outputs
Outputs of similar age from Frontiers in Pharmacology
#155
of 588 outputs
Altmetric has tracked 23,870,007 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,727 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,767 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 588 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.